Maternal and newborn immunization with a human immunodeficiency virus-1 immunogen in a rodent model

Immunology

Volumn 106, Issue 4, 2002, Pages 549-553

  Moss, Ronald B ^a   Savary, Jay R ^a   Diveley, Jocelyn P ^a   Jensen, Fred ^a   Carlo, Dennis J ^a  

^a Orchestra Therapeutics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; DNA; FREUND ADJUVANT; GAMMA INTERFERON; HUMAN IMMUNODEFICIENCY VIRUS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; RANTES;

AGE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL SECRETION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA SEQUENCE; DRUG EFFECT; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGLOBULIN PRODUCTION; IMMUNOSTIMULATION; MATERNAL CARE; MONONUCLEAR CELL; NEWBORN CARE; NEWBORN PERIOD; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN SYNTHESIS; SUPERNATANT; THIRD TRIMESTER PREGNANCY; VIRUS ACTIVATION; VIRUS TRANSMISSION;

AIDS VACCINES; ANIMALS; ANIMALS, NEWBORN; FEMALE; FREUND'S ADJUVANT; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; IMMUNOGLOBULIN G; INTERFERON TYPE II; LIPIDS; PREGNANCY; RANTES; RATS; RATS, INBRED LEW;

EID: 0036038817     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.2002.01464.x     Document Type: Article

References (20)

1. Human immunodeficiency virus (HIV)-specific immune responses are generated with the simultaneous vaccination of a gp120-depleted, whole-killed HIV-1 immunogen with cytosine-phosphorothioate-guanine dinucleotide immunostimulatory sequences of DNA
2. HIV-specific CD4 (+) and CD8 (+) immune responses are generated with a gp120-depleted, whole-killed HIV-1 immunogen with CpG immunostimulatory sequences of DNA
3. In vitro immune function after vaccination with an inactivated, gp120-depleted HIV-1 antigen with immunostimulatory oligodeoxynucleotides
4. Sequence note: HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant
5. Process development for the manufacture of inactivated HIV-1
6. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants
7. CpG DNA as a Th1 trigger
8. Immunostimulatory bacterial DNA sequences activate dendritic cells and promote priming and differentiation of CD8+ T cells
9. Association between HIV-specific T helper responses and CTL activities in pediatric AIDS
10. Cytokine patterns during progression to AIDS in children with perinatal HIV infection
11. Protective role of beta-chemokines associated with HIV-specific Th responses against perinatal HIV transmission
12. + T-cell-mediated suppression of HIV replication in the first year of life: Association with lower viral load and favorable early survival
13. Neutralizing antibody-independent containment of immunodeficiency virus challenges by DNA priming and recombinant pox virus booster immunizations
14. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
15. Transplacental genetic immunization after intravenous delivery of plasmid DNA to pregnant mice
16. Protective mucosal immunity elicited by targeted iliac lymph node immunization with a subunit SIV envelope and core vaccine in macaques
17. Spontaneous and antigen-induced production of HIV-inhibitory beta-chemokines are associated with AIDS-free status
18. Preliminary evaluation of human immunodeficiency virus type 1 (HIV-1) immunogen in children with HIV-1 infection
19. Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines
20. Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children